Prescription Drug Copays and Their Effect on Vulnerable Populations
This supplement to
The American Journal of Managed Care
is based on a closed-panel roundtable meeting held in Philadelphia, Pennsylvania, on June 13, 2006, in which 5 experts in various fields discussed prescription drug copays and their effect on vulnerable populations.
Faculty
Michael E. Chernew, PhDProfessor of Healthcare Policy
Boston, Massachusetts
William Fleming, PharmDVice President, Pharmacy and Clinical Integration
Louisville, Kentucky
John J. Mahoney, MDCorporate Medical Director
Stamford, Connecticut
David Nash, MD, MBADr. Raymond C. and Doris N. Grandon Professorof Health PolicyChairman, Department of Health Policy
Philadelphia, Pennsylvania
Richard C. Surles, PhDExecutive Vice President
Pennington, New Jersey